Jason Brinkley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jason Brinkley has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Anastasios A. Tsiatis
Department of Statistics, North Carolina State University, Raleigh, NC 27695, USA
1 shared publication Jennifer Mann
Department of Statistics The Ohio State University USA
1 shared publication- Kevin Joseph Anstrom
The University of North Carolina at Chapel Hill
1 shared publication Pamela Larsen
Department of Pediatrics Brody School of Medicine East Carolina University USA
1 shared publication
Latest Publications
- 26 September 2014
- Published by Wiley in Statistics in Medicine
- Vol. 33 (29) , 5057-5073
A doubly robust estimator for the attributable benefit of a treatment regime
- 26 September 2014
- Published by Wiley in Statistics in Medicine
- Vol. 33 (29) , 5057-5073
A doubly robust estimator for the attributable benefit of a treatment regime
- Open Access
- 1 January 2014
- Published by Herbert Publications PVT LTD in Journal of Medical Statistics and Informatics
- Vol. 2 (1) , 6
Exploring the use of negative binomial regression modeling for pediatric peripheral intravenous catheterization
A large study conducted at two southeastern US hospitals from October 2007 through October 2008 sought to identify predictive variables for successful intravenous catheter (IV) insertion, a procedure that is potentially
- 1 January 2014
- Published by Herbert Publications PVT LTD in Journal of Medical Statistics and Informatics
- Vol. 2 (1) , 6
Open AccessExploring the use of negative binomial regression modeling for pediatric peripheral intravenous catheterization
A large study conducted at two southeastern US hospitals from October 2007 through October 2008 sought to identify predictive variables for successful intravenous catheter (IV) insertion, a procedure that is potentially
- 1 June 2010
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 66 (2) , 512-522
A Generalized Estimator of the Attributable Benefit of an Optimal Treatment Regime
Summary For many diseases where there are several treatment options often there is no consensus on the best treatment to give individual patients. In such cases, it may be necessary to define a strategy for treatment assignment; that is, an algorithm that dictates the treatment an individual should receive based on their measured characteristics. Such a strategy or algorithm is also referred to as a treatment regime. The optimal treatment regime is the strategy that would provide the most public health benefit by minimizing as many poor outcomes as possible. Using a measure that is a generalization of attributable risk (AR) and notions of potential outcomes, we derive an estimator for the proportion of events that could have been prevented had the optimal treatment regime been implemented. Traditional AR studies look at the added risk that can be attributed to exposure of some contaminant; here we will instead study the benefit that can be attributed to using the optimal treatment strategy. We will show how regression models can be used to estimate the optimal treatment strategy and the attributable benefit of that strategy. We also derive the large sample properties of this estimator. As a motivating example, we will apply our methods to an observational study of 3856 patients treated at the Duke University Medical Center with prior coronary artery bypass graft surgery and further heart‐related problems requiring a catheterization. The patients may be treated with either medical therapy alone or a combination of medical therapy and percutaneous coronary intervention without a general consensus on which is the best treatment for individual patients.
- 1 June 2010
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 66 (2) , 512-522
A Generalized Estimator of the Attributable Benefit of an Optimal Treatment Regime
Summary For many diseases where there are several treatment options often there is no consensus on the best treatment to give individual patients. In such cases, it may be necessary to define a strategy for treatment assignment; that is, an algorithm that dictates the treatment an individual should receive based on their measured characteristics. Such a strategy or algorithm is also referred to as a treatment regime. The optimal treatment regime is the strategy that would provide the most public health benefit by minimizing as many poor outcomes as possible. Using a measure that is a generalization of attributable risk (AR) and notions of potential outcomes, we derive an estimator for the proportion of events that could have been prevented had the optimal treatment regime been implemented. Traditional AR studies look at the added risk that can be attributed to exposure of some contaminant; here we will instead study the benefit that can be attributed to using the optimal treatment strategy. We will show how regression models can be used to estimate the optimal treatment strategy and the attributable benefit of that strategy. We also derive the large sample properties of this estimator. As a motivating example, we will apply our methods to an observational study of 3856 patients treated at the Duke University Medical Center with prior coronary artery bypass graft surgery and further heart‐related problems requiring a catheterization. The patients may be treated with either medical therapy alone or a combination of medical therapy and percutaneous coronary intervention without a general consensus on which is the best treatment for individual patients.